Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(2 sites)
United States
University of California Davis Comprehensive Cancer Center, Sacramento, California UC San Diego Moores Cancer Center, San Diego, California Age range
18 Years and older
Last updated November 2025